» Articles » PMID: 29623044

Long-Term Intermittent Work at High Altitude: Right Heart Functional and Morphological Status and Associated Cardiometabolic Factors

Overview
Journal Front Physiol
Date 2018 Apr 7
PMID 29623044
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Living at high altitude or with chronic hypoxia implies functional and morphological changes in the right ventricle and pulmonary vasculature with a 10% prevalence of high-altitude pulmonary hypertension (HAPH). The implications of working intermittently (day shifts) at high altitude (hypobaric hypoxia) over the long term are still not well-defined. The aim of this study was to evaluate the right cardiac circuit status along with potentially contributory metabolic variables and distinctive responses after long exposure to the latter condition. A cross-sectional study of 120 healthy miners working at an altitude of 4,400-4,800 m for over 5 years in 7-day commuting shifts was designed. Echocardiography was performed on day 2 at sea level. Additionally, biomedical and biochemical variables, Lake Louise scores (LLSs), sleep disturbances and physiological variables were measured at altitude and at sea level. The population was 41.8 ± 0.7 years old, with an average of 14 ± 0.5 (range 5-29) years spent at altitude. Most subjects still suffered from mild to moderate symptoms of acute mountain sickness (mild was an LLS of 3-5 points, including cephalea; moderate was LLS of 6-10 points) (38.3%) at the end of day 1 of the shift. Echocardiography showed a 23% mean pulmonary artery pressure (mPAP) >25 mmHg, 9% HAPH (≥30 mmHg), 85% mild increase in right ventricle wall thickness (≥5 mm), 64% mild right ventricle dilation, low pulmonary vascular resistance (PVR) and fairly good ventricle performance. Asymmetric dimethylarginine (ADMA) (OR 8.84 (1.18-66.39); < 0.05) and insulin (OR: 1.11 (1.02-1.20); < 0.05) were associated with elevated mPAP and were defined as a cut-off. Interestingly, the correspondence analysis identified association patterns of several other variables (metabolic, labor, and biomedical) with higher mPAP. Working intermittently at high altitude involves a distinctive pattern. The most relevant and novel characteristics are a greater prevalence of elevated mPAP and HAPH than previously reported at chronic intermittent hypobaric hypoxia (CIHH), which is accompanied by subsequent morphological characteristics. These findings are associated with cardiometabolic factors (insulin and ADMA). However, the functional repercussions seem to be minor or negligible. This research contributes to our understanding and surveillance of this unique model of chronic intermittent high-altitude exposure.

Citing Articles

mTOR in the Development of Hypoxic Pulmonary Hypertension Associated with Cardiometabolic Risk Factors.

Flores K, Almeida C, Arriaza K, Pena E, El Alam S Int J Mol Sci. 2024; 25(20).

PMID: 39456805 PMC: 11508063. DOI: 10.3390/ijms252011023.


Astaxanthin Supplementation Effects in Right Ventricle of Rats Exposed to Chronic Intermittent Hypobaric Hypoxia.

Pena E, El Alam S, Gonzalez C, Cortes I, Aguilera D, Flores K Antioxidants (Basel). 2024; 13(10).

PMID: 39456521 PMC: 11504862. DOI: 10.3390/antiox13101269.


Mountain sickness in altitude inhabitants of Latin America: A systematic review and meta-analysis.

Zila-Velasque J, Grados-Espinoza P, Goicochea-Romero P, Tapia-Sequeiros G, Pascual-Aguilar J, Ruiz-Yaringano A PLoS One. 2024; 19(9):e0305651.

PMID: 39316567 PMC: 11421813. DOI: 10.1371/journal.pone.0305651.


Work at high altitude and non-fatal cardiovascular disease associated with unfitness to work: Prospective cohort observation.

Vinnikov D, Saktapov A, Romanova Z, Ualiyeva A, Krasotski V PLoS One. 2024; 19(7):e0306046.

PMID: 38976716 PMC: 11230562. DOI: 10.1371/journal.pone.0306046.


A novel clinical prediction scoring system of high-altitude pulmonary hypertension.

Zeng Y, Zhakeer G, Li B, Yu Q, Niu M, Maimaitiaili N Front Cardiovasc Med. 2024; 10:1290895.

PMID: 38259305 PMC: 10801263. DOI: 10.3389/fcvm.2023.1290895.


References
1.
Schwedhelm E, Xanthakis V, Maas R, Sullivan L, Schulze F, Riederer U . Asymmetric dimethylarginine reference intervals determined with liquid chromatography-tandem mass spectrometry: results from the Framingham offspring cohort. Clin Chem. 2009; 55(8):1539-45. PMC: 3794429. DOI: 10.1373/clinchem.2009.124263. View

2.
Brito J, Siques P, Arribas S, Lopez de Pablo A, Gonzalez M, Naveas N . Adventitial alterations are the main features in pulmonary artery remodeling due to long-term chronic intermittent hypobaric hypoxia in rats. Biomed Res Int. 2015; 2015:169841. PMC: 4337174. DOI: 10.1155/2015/169841. View

3.
Chobanian A, Bakris G, Black H, Cushman W, Green L, Izzo Jr J . Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42(6):1206-52. DOI: 10.1161/01.HYP.0000107251.49515.c2. View

4.
Boger R, Maas R, Schulze F, Schwedhelm E . Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality--an update on patient populations with a wide range of cardiovascular risk. Pharmacol Res. 2009; 60(6):481-7. DOI: 10.1016/j.phrs.2009.07.001. View

5.
Zoccali C, Mallamaci F, Benedetto F, Tripepi G, Malatino L, Cataliotti A . Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet. 2002; 358(9299):2113-7. DOI: 10.1016/s0140-6736(01)07217-8. View